<DOC>
	<DOCNO>NCT01789060</DOCNO>
	<brief_summary>PI3K ( phosphatidylinositol 3-kinase ) /AKT pathway important oncogenic signal pathway . However , clinical information significance p-AKT expression malignant lymphoma fully understood yet . In study , investigate overexpression p-AKT prognostic implication malignant lymphoma .</brief_summary>
	<brief_title>p-AKT Expression Clinical Outcomes Malignant Lymphoma</brief_title>
	<detailed_description>Recently , among diverse oncogenic signaling pathway , number study focus significance oncogenic PI3K/AKT ( phophatidylinositol 3-kinase/serine-threonine kinase , also know protein kinase B [ PKB ] ) pathway . PI3K ( phosphatidylinositol 3-kinase ) /AKT pathway phosphorylates activate AKT phosphorylated AKT ( p-AKT ) play critical role promote malignant phenotype prognostic significance various solid cancer . However , systematic approach impact p-AKT overexpression clinical outcome perform malignant lymphoma .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<criteria>1. patient pathologically confirm malignant lymphoma , accord World Health Organization classification ; 2. patient adequate paraffinembedded biopsy specimen unstained slide immunostaining pAKT . 1 . Primary central nervous system lymphoma exclude study</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>